These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35949431)

  • 1. Significance of serum carcinoembryonic antigen in metastatic breast cancer patients: A prospective study.
    Anoop TM; Joseph P R; Soman S; Chacko S; Mathew M
    World J Clin Oncol; 2022 Jun; 13(6):529-539. PubMed ID: 35949431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of bone marker measurements for monitoring response to bisphosphonate therapy with zoledronic acid in metastatic breast cancer.
    Aktas B; Kasimir-Bauer S; Lehmann N; Kimmig R; Tewes M
    Oncol Rep; 2013 Jul; 30(1):441-7. PubMed ID: 23604361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CA 15-3 and CEA with clinicopathological parameters in patients with metastatic breast cancer.
    Geng B; Liang MM; Ye XB; Zhao WY
    Mol Clin Oncol; 2015 Jan; 3(1):232-236. PubMed ID: 25469301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease.
    Colomer R; Ruibal A; Salvador L
    Cancer; 1989 Oct; 64(8):1674-81. PubMed ID: 2790682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between circulating carcinoembryonic antigen (CEA) levels and parameters of primary tumor and metastases in breast cancer patients.
    Mujagić Z; Mujagic H; Prnjavorac B
    Med Arh; 2004; 58(1):23-6. PubMed ID: 15017899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Carcinoembryonic Antigen Levels and the Risk of Whole-body Metastatic Potential in Advanced Non-small Cell Lung Cancer.
    Lee DS; Kim SJ; Kang JH; Hong SH; Jeon EK; Kim YK; Yoo IeR; Park JG; Jang HS; Lee HC; Kim YS
    J Cancer; 2014; 5(8):663-9. PubMed ID: 25258647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
    Nicolini A; Colombini C; Luciani L; Carpi A; Giuliani L
    Br J Cancer; 1991 Jul; 64(1):154-8. PubMed ID: 1854615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cytokeratin 19 fragment 21-1 and carcinoembryonic antigen combination assay as a biomarker of tumour progression and treatment response in extramammary Paget disease.
    Nakamura Y; Tanese K; Hirai I; Amagai M; Kawakami Y; Funakoshi T
    Br J Dermatol; 2019 Sep; 181(3):535-543. PubMed ID: 30791097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
    Cheong C; Shin JS; Suh KW
    World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The objective measurement of remission and progression in metastatic breast cancer by use of serum tumour markers. European Group for Serum Tumour Markers in Breast Cancer.
    Robertson JF; Jaeger W; Syzmendera JJ; Selby C; Coleman R; Howell A; Winstanley J; Jonssen PE; Bombardieri E; Sainsbury JR; Gronberg H; Kumpulainen E; Blamey RW
    Eur J Cancer; 1999 Jan; 35(1):47-53. PubMed ID: 10211087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic usefulness of serum carcinoembryonic antigen determinations in breast cancer patients.
    Mujagić Z; Mujagić H
    Bosn J Basic Med Sci; 2003 May; 3(2):30-4. PubMed ID: 16223370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer.
    Loprinzi CL; Tormey DC; Rasmussen P; Falkson G; Davis TE; Falkson HC; Chang AY
    J Clin Oncol; 1986 Jan; 4(1):46-56. PubMed ID: 3510282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen as prognostic factor for metastatic non-small cell lung cancer by percutaneous cryosurgery.
    Li H; Tang K; Niu L; Liang Y; Li J; Chen J; Xu K
    Cancer Biomark; 2013; 13(5):337-43. PubMed ID: 24440973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of serum CEA and CA15-3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients.
    Yang Y; Zhang H; Zhang M; Meng Q; Cai L; Zhang Q
    Oncol Lett; 2017 Dec; 14(6):7549-7556. PubMed ID: 29344201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
    Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
    Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic monitoring of carcinoembryonic antigen, CA19-9 and inflammation-based indices in patients with advanced colorectal cancer undergoing chemotherapy.
    Manojlovic N; Savic G; Nikolic B; Rancic N
    World J Clin Cases; 2022 Jan; 10(3):899-918. PubMed ID: 35127905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers.
    Lee JS; Park S; Park JM; Cho JH; Kim SI; Park BW
    Breast Cancer Res Treat; 2013 Oct; 141(3):477-84. PubMed ID: 24072270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
    Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
    Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.